157 related articles for article (PubMed ID: 27725124)
1. Serum concentration of CD40L is elevated in inflammatory demyelinating diseases.
Zhong X; Wang H; Ye Z; Qiu W; Lu Z; Li R; Shu Y; Chang Y; Hu X
J Neuroimmunol; 2016 Oct; 299():66-69. PubMed ID: 27725124
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets.
Ip PP; Chung CY; Chang CC; Lee YF; Wang HM; Lian IB; Fann CS; Yang CC; Liao F
J Neuroimmunol; 2018 May; 318():45-52. PubMed ID: 29455925
[TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
[TBL] [Abstract][Full Text] [Related]
4. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica.
Tortorella C; Ruggieri M; Di Monte E; Ceci E; Iaffaldano P; Direnzo V; Mastrapasqua M; Frigeri A; Amato MP; Hakiki B; Ghezzi A; Lugaresi A; De Luca G; Patti F; D'Amico E; Sola P; Simone AM; Svelto M; Livrea P; Trojano M
J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1355-9. PubMed ID: 21622936
[TBL] [Abstract][Full Text] [Related]
5. Serum analysis by 1H nuclear magnetic resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
Moussallieh FM; Elbayed K; Chanson JB; Rudolf G; Piotto M; De Seze J; Namer IJ
Mult Scler; 2014 Apr; 20(5):558-65. PubMed ID: 24080986
[TBL] [Abstract][Full Text] [Related]
6. Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission.
Wang S; Yang T; Wan J; Zhang Y; Fan Y
Brain Behav; 2017 Apr; 7(4):e00648. PubMed ID: 28413701
[TBL] [Abstract][Full Text] [Related]
7. Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder.
Hakobyan S; Luppe S; Evans DR; Harding K; Loveless S; Robertson NP; Morgan BP
Mult Scler; 2017 Jun; 23(7):946-955. PubMed ID: 27613120
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.
Wu A; Zhong X; Wang H; Xu W; Cheng C; Dai Y; Bao J; Qiu W; Lu Z; Hu X
Can J Neurol Sci; 2012 Nov; 39(6):813-20. PubMed ID: 23041403
[TBL] [Abstract][Full Text] [Related]
9. Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis.
Correale J; Fiol M
Mult Scler; 2011 May; 17(5):521-31. PubMed ID: 21159721
[TBL] [Abstract][Full Text] [Related]
10. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis.
Farrokhi M; Saadatpour Z; Fadaee E; Saadatpour L; Rezaei A; Moeini P; Amani Beni A
Iran J Allergy Asthma Immunol; 2016 Dec; 15(6):536-546. PubMed ID: 28129686
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
Wang H; Wang K; Wang C; Zhong X; Qiu W; Hu X
Mult Scler; 2013 Jun; 19(7):926-31. PubMed ID: 23012252
[TBL] [Abstract][Full Text] [Related]
12. [CD40L expression on T CD4+ lymphocytes from peripheral blood in patients with relapsing-remitting and secondary progressive multiple sclerosis].
Bilińska M; Frydecka I; Kosmaczewska A; Ciszak L; Koszewicz M; Pokryszko-Dragan A
Pol Merkur Lekarski; 2006 Jan; 20(115):41-5. PubMed ID: 16617733
[TBL] [Abstract][Full Text] [Related]
13. Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis.
Feng X; Reder NP; Yanamandala M; Hill A; Franek BS; Niewold TB; Reder AT; Javed A
J Neurol Sci; 2012 Feb; 313(1-2):48-53. PubMed ID: 22036215
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
Zhong X; Wang H; Dai Y; Wu A; Bao J; Xu W; Cheng C; Lu Z; Qiu W; Hu X
J Neuroimmunol; 2011 Dec; 240-241():104-8. PubMed ID: 22036953
[TBL] [Abstract][Full Text] [Related]
15. B-cell activating factor of the TNF family is upregulated in neuromyelitis optica.
Okada K; Matsushita T; Kira J; Tsuji S
Neurology; 2010 Jan; 74(2):177-8. PubMed ID: 20065253
[No Abstract] [Full Text] [Related]
16. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of the membrane-bound CD40 ligand on peripheral CD4
Liu J; Zhang Q; Shi Z; Yang M; Lian Z; Chen H; Feng H; Du Q; Zhang Y; Miao X; Li H; Zhou H
J Neuroimmunol; 2018 Dec; 325():64-68. PubMed ID: 30408708
[TBL] [Abstract][Full Text] [Related]
18. Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse.
Wang H; Wang K; Zhong X; Dai Y; Wu A; Li Y; Hu X
J Neuroimmunol; 2012 Feb; 243(1-2):52-5. PubMed ID: 22177277
[TBL] [Abstract][Full Text] [Related]
19. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
Wang KC; Lee CL; Chen SY; Chen JC; Yang CW; Chen SJ; Tsai CP
J Interferon Cytokine Res; 2013 Feb; 33(2):58-64. PubMed ID: 23398365
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A level is increased in neuromyelitis optica and atypical multiple sclerosis with smaller T2 lesion volume in brain MRI.
Yokote H; Yagi Y; Watanabe Y; Amino T; Kamata T; Mizusawa H
J Neuroimmunol; 2013 Jun; 259(1-2):92-5. PubMed ID: 23566403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
